BIO kicks off ‘Fight of Our Lives,’ highlighting urgency of biotech progress at Axios event
As biotech celebrates its 50th year, we are locked in “the fight of our lives” to ensure patients get more of the medical innovations […]
As biotech celebrates its 50th year, we are locked in “the fight of our lives” to ensure patients get more of the medical innovations […]
Since its founding in 1920, the National Health Council (NHC) has brought diverse organizations together to forge consensus and drive patient-centered health policy in
Q&A with National Health Council: Driving patient-centred policy Read More »
At some point in our lives, many of us will find ourselves in a health fight we didn’t expect. A diagnosis. A test result.
Patient advocacy is a driving force behind some of today’s most promising breakthroughs in biotechnology—where progress is increasingly powered by strong, productive collaboration between
BIO Coffee Chat explores venture philanthropy Read More »
“Biotechnology innovation is advancing at an unprecedented pace, delivering new treatments and cures that offer long-awaited hope to patients and their families,” said Karin
BIO Coffee Chat: Price controls like MFN harm access, increase costs Read More »
Ensuring a brighter future for U.S. biotech requires modernizing the Food and Drug Administration (FDA) and addressing challenges from China, according to Kelly Seagraves,
BIO expert: Future of biotech depends on competing with China, updating FDA Read More »
Strong intellectual property protections sustain biotechnology innovation by enabling the investment needed to develop new medical breakthroughs. In comments submitted for the 2026 U.S.
BIO’s comments for USTR report highlight global threats to intellectual property Read More »
The field of bleeding disorders has seen monumental transformation. For many patients, biotech innovation has turned what was once a fatal diagnosis with a
Biotech innovation makes inroads against bleeding disorders Read More »
A year after a congressional commission urged strategic action to prevent China from replacing America as the world leader in biotechnology, we still have
BIO CEO hails congressional report on threat of China dominating biotech Read More »
Voters see a better path than Most Favored Nation to ensure access and affordability of innovative medicines Eight in 10 American voters would be
Poll: U.S. voters want PBM and insurance reform—and strong biotech Read More »